Back

Host genetics and pre-vaccination blood transcriptome as determinants of vaccine-induced immunity to Influenza A virus in swine

Blanc, F.; Maroilley, T.; Lemonnier, G.; Ravon, L.; Billon, Y.; BOUCHEZ, O.; Pinard van der Laan, M.-H.; ESTELLE, J.; Rogel-Gaillard, C.

2026-02-07 genomics
10.64898/2026.02.06.700797 bioRxiv
Show abstract

Influenza A virus (IAV) is a major respiratory pathogen in pigs, causing diseases that have significant economic and potential public health consequences. Vaccine effectiveness varies among animals, impacting long-term herd protection due to individual variabilities in antibody levels and persistence over time. Our aim was to identify the genetic factors and pre-vaccination blood transcriptomic profiles that influence immune response levels to the IAV vaccine. A total of 187 piglets were vaccinated at weaning (28 days of age, 0 days post-vaccination, dpv) and boosted three weeks later, and humoral responses were assessed until slaughter (21, 28, 35, and 118 dpv) by measuring serum IAV-specific IgG and hemagglutination inhibition (HAI) titers. The results revealed varying antibody responses and persistence. Genome-wide association studies identified two loci on chromosomes SSC5 and SSC8 associated with a persistence of HAI titers until slaughter. Pre-vaccination blood transcriptomic analyses showed that early and post-boost antibody responses (21, 28 and 35 dpv) and long-term persistence (118 dpv) were associated with distinct baseline immune programs, with extracellular matrix and myeloid-related signatures predicting strong early and peak responses, whereas interferon-related signatures were linked to reduced long-term antibody persistence. Our results highlight the importance of considering the role of immune competence and genetics in vaccine responses in pigs and suggest candidate biomarkers to improve vaccination strategies within breeding programs.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
586 papers in training set
Top 0.4%
12.2%
2
Viruses
318 papers in training set
Top 0.9%
6.3%
3
Emerging Microbes & Infections
74 papers in training set
Top 0.1%
6.2%
4
Frontiers in Genetics
197 papers in training set
Top 0.9%
6.2%
5
PLOS Pathogens
721 papers in training set
Top 2%
6.2%
6
Scientific Reports
3102 papers in training set
Top 25%
4.8%
7
PLOS ONE
4510 papers in training set
Top 36%
3.9%
8
Genomics
60 papers in training set
Top 0.2%
3.9%
9
BMC Genomics
328 papers in training set
Top 0.9%
3.5%
50% of probability mass above
10
Vaccines
196 papers in training set
Top 0.7%
3.5%
11
Journal of Virology
456 papers in training set
Top 1%
3.5%
12
Nature Communications
4913 papers in training set
Top 44%
2.7%
13
Genome Medicine
154 papers in training set
Top 3%
2.3%
14
Transboundary and Emerging Diseases
34 papers in training set
Top 0.3%
1.9%
15
Journal of Infection
71 papers in training set
Top 1%
1.7%
16
iScience
1063 papers in training set
Top 16%
1.7%
17
Frontiers in Microbiology
375 papers in training set
Top 6%
1.6%
18
mSystems
361 papers in training set
Top 5%
1.5%
19
GigaScience
172 papers in training set
Top 2%
1.3%
20
Vaccine
189 papers in training set
Top 2%
0.9%
21
Microbial Genomics
204 papers in training set
Top 2%
0.9%
22
Cell Reports
1338 papers in training set
Top 32%
0.8%
23
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.7%
24
Animal Microbiome
26 papers in training set
Top 0.3%
0.7%
25
International Journal of Biological Macromolecules
65 papers in training set
Top 4%
0.7%
26
Communications Biology
886 papers in training set
Top 25%
0.7%
27
EBioMedicine
39 papers in training set
Top 1%
0.7%
28
Pathogens
53 papers in training set
Top 2%
0.6%
29
Microbiology Spectrum
435 papers in training set
Top 6%
0.6%
30
Biology
43 papers in training set
Top 4%
0.6%